메뉴 건너뛰기




Volumn 61, Issue 1, 2014, Pages 9-16

Relation of ETS transcription factor family member ERG, androgen receptor and topoisomerase 2β expression to TMPRSS2-ERG fusion status in prostate cancer

Author keywords

Androgen receptor; ERG; Prostate cancer; TMPRSS2 ERG fusion; Topoisomerase 2

Indexed keywords

ANDROGEN RECEPTOR; DNA TOPOISOMERASE; DNA TOPOISOMERASE 2 BETA; SERINE PROTEINASE; TRANSCRIPTION FACTOR ERG; UNCLASSIFIED DRUG;

EID: 84893180523     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2014_004     Document Type: Article
Times cited : (12)

References (18)
  • 1
    • 77955069195 scopus 로고    scopus 로고
    • Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
    • HAFFNER MC, ARYEE MJ, TOUBAJI A, ESOPI DM, ALBADINE R et al. Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat Genet 2010; 42: 668-675. http://dx.doi.org/10.1038/ng.613
    • (2010) Nat Genet , vol.42 , pp. 668-675
    • Haffner, M.C.1    Aryee, M.J.2    Toubaji, A.3    Esopi, D.M.4    Albadine, R.5
  • 2
    • 77955069822 scopus 로고    scopus 로고
    • On the origin of prostate fusion oncogenes
    • BARTEK J, HAMERLIK P, LUKAS J. On the origin of prostate fusion oncogenes. Nat Genet 2010; 42: 647-648. http://dx.doi.org/10.1038/ng0810-647
    • (2010) Nat Genet , vol.42 , pp. 647-648
    • Bartek, J.1    Hamerlik, P.2    Lukas, J.3
  • 3
    • 78649966606 scopus 로고    scopus 로고
    • Androgen-induced TMPRSS2: ERG fusion in nonmalignant prostate epithelial cells
    • BASTUS NC, BOYD LK, MAO X, STANKIEWICZ E, KUDAHETTI SC et al. Androgen-induced TMPRSS2: ERG fusion in nonmalignant prostate epithelial cells. Cancer Res 2010; 70: 9544-9548. http://dx.doi.org/10.1158/0008-5472.CAN-10-1638
    • (2010) Cancer Res , vol.70 , pp. 9544-9548
    • Bastus, N.C.1    Boyd, L.K.2    Mao, X.3    Stankiewicz, E.4    Kudahetti, S.C.5
  • 4
    • 82555172358 scopus 로고    scopus 로고
    • Androgen receptor-driven chromatin Looping in prostate cancer
    • WU D, ZHANG C, SHEN Y, NEPHEW K, WANG Q. Androgen receptor-driven chromatin Looping in prostate cancer. Trends Endocrinol Metab 2011; 22: 474-480. http://dx.doi.org/10.1016/j.tem.2011.07.006
    • (2011) Trends Endocrinol Metab , vol.22 , pp. 474-480
    • Wu, D.1    Zhang, C.2    Shen, Y.3    Nephew, K.4    Wang, Q.5
  • 5
    • 77952103123 scopus 로고    scopus 로고
    • An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression
    • YU J, YU J, MANI RS, CAO Q, BRENNER CJ et al. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 2010; 17: 443-454. http://dx.doi.org/10.1016/j.ccr.2010.03.018
    • (2010) Cancer Cell , vol.17 , pp. 443-454
    • Yu, J.1    Yu, J.2    Mani, R.S.3    Cao, Q.4    Brenner, C.J.5
  • 6
    • 79951497419 scopus 로고    scopus 로고
    • The genomic complexity of primary human prostate cancer
    • BERGER MF, LAWRENCE MS, DEMICHELIS F, DRIER Y, CIBULSKIS K et al. The genomic complexity of primary human prostate cancer. Nature 2011; 470: 214-220. http://dx.doi.org/10.1038/nature09744
    • (2011) Nature , vol.470 , pp. 214-220
    • Berger, M.F.1    Lawrence, M.S.2    Demichelis, F.3    Drier, Y.4    Cibulskis, K.5
  • 7
    • 79951846237 scopus 로고    scopus 로고
    • Gene fusions find an ERG-way to tumor inflammation
    • MARTIN SK, KYPRIANOU N. Gene fusions find an ERG-way to tumor inflammation. Cancer Biol Ther 2011; 11: 418-420. http://dx.doi.org/10.4161/cbt.11.4.14499
    • (2011) Cancer Biol Ther , vol.11 , pp. 418-420
    • Martin, S.K.1    Kyprianou, N.2
  • 8
    • 79951838697 scopus 로고    scopus 로고
    • ERG oncogene modulates prostaglandin signaling in prostate cancer cells
    • MOHAMED AA, TAN SH, SUN C, SHAHEDUZZAMAN S, HU Y. et al. ERG oncogene modulates prostaglandin signaling in prostate cancer cells. Cancer Biol Ther 2011; 11: 410-417. http://dx.doi.org/10.4161/cbt.11.4.14180
    • (2011) Cancer Biol Ther , vol.11 , pp. 410-417
    • Mohamed, A.A.1    Tan, S.H.2    Sun, C.3    Shaheduzzaman, S.4    Hu, Y.5
  • 11
    • 80052841071 scopus 로고    scopus 로고
    • ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy
    • MINNER S, ENODIEN M, SIRMA H, LUEBKE AM, KROHN A et al. ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy. Clin Cancer Res 2011; 17: 5878-5888. http://dx.doi.org/10.1158/1078-0432.CCR-11-1251
    • (2011) Clin Cancer Res , vol.17 , pp. 5878-5888
    • Minner, S.1    Enodien, M.2    Sirma, H.3    Luebke, A.M.4    Krohn, A.5
  • 12
    • 33749029695 scopus 로고    scopus 로고
    • TMPRSS2: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
    • PERNER S, DEMICHELIS F, BEROUKHIM R, SCHMIDT FH, MOSQUERA JM et al. TMPRSS2: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res 2006; 66: 8337-8341. http://dx.doi.org/10.1158/0008-5472.CAN-06-1482
    • (2006) Cancer Res , vol.66 , pp. 8337-8341
    • Perner, S.1    Demichelis, F.2    Beroukhim, R.3    Schmidt, F.H.4    Mosquera, J.M.5
  • 13
    • 34248510706 scopus 로고    scopus 로고
    • TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
    • DEMICHELIS F, FALL K, PERNER S, ANDREN O, SCHMIDT F et al. TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene 2007; 26: 4596-4599. http://dx.doi.org/10.1038/sj.onc.1210237
    • (2007) Oncogene , vol.26 , pp. 4596-4599
    • Demichelis, F.1    Fall, K.2    Perner, S.3    Andren, O.4    Schmidt, F.5
  • 14
    • 84862776695 scopus 로고    scopus 로고
    • ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortality
    • BISMAR TA, DOLPH M, TENG LH, LIU S, DONNELLY B. ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortality. Eur J Cancer 2012; 48: 538-46. http://dx.doi.org/10.1016/j.ejca.2012.01.001
    • (2012) Eur J Cancer , vol.48 , pp. 538-546
    • Bismar, T.A.1    Dolph, M.2    Teng, L.H.3    Liu, S.4    Donnelly, B.5
  • 15
    • 84861165073 scopus 로고    scopus 로고
    • Correlation of ERG expression and DNA methylation biomarkers with adverse clinicopathologic features of prostate cancer
    • KRON K, LJU L, TRUDEL D, KRON K, LJU L, TRUDEL D. Correlation of ERG expression and DNA methylation biomarkers with adverse clinicopathologic features of prostate cancer. Clin Cancer Res 2012; 18: 2896-2904. http://dx.doi.org/10.1158/1078-0432.CCR-11-2901
    • (2012) Clin Cancer Res , vol.18 , pp. 2896-2904
    • Kron, K.1    Lju, L.2    Trudel, D.3    Kron, K.4    Lju, L.5    Trudel, D.6
  • 16
    • 79959660044 scopus 로고    scopus 로고
    • Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas
    • CHAUX A, ALBADINE R, TOUBAJI A, HICKS J, MEEKER A et al. Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas. Am J Surg Pathol 2011; 35: 1014-1020. http://dx.doi.org/10.1097/PAS.0b013e31821e8761
    • (2011) Am J Surg Pathol , vol.35 , pp. 1014-1020
    • Chaux, A.1    Albadine, R.2    Toubaji, A.3    Hicks, J.4    Meeker, A.5
  • 17
    • 77954997528 scopus 로고    scopus 로고
    • Antibody-based detection of ERG rearrangement-positive prostate cancer
    • PARK K, TOMLINS SA, MUDALIAR KM, CHIU YL, ESGUEVA R et al. Antibody-based detection of ERG rearrangement-positive prostate cancer. Neoplasia 2010; 12: 590-598.
    • (2010) Neoplasia , vol.12 , pp. 590-598
    • Park, K.1    Tomlins, S.A.2    Mudaliar, K.M.3    Chiu, Y.L.4    Esgueva, R.5
  • 18
    • 79961031183 scopus 로고    scopus 로고
    • Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: Implications for pathological practice
    • VAN LEENDERS GJ, BOORMANS JL, VISSERS CJ, HOOGLAND AM, BRESSERS AA et al. Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice. Mod Pathol 2011; 24: 1128-1138. http://dx.doi.org/10.1038/modpathol.2011.65
    • (2011) Mod Pathol , vol.24 , pp. 1128-1138
    • Van Leenders, G.J.1    Boormans, J.L.2    Vissers, C.J.3    Hoogland, A.M.4    Bressers, A.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.